pre-update Archives

Publication

Activities of Ceftazidime and Avibactam Against β-lactamase-producing Enterobacteriaceae in a Hollow-fiber Pharmacodynamic Model

Avibactam is a novel non-β-lactam β-lactamase inhibitor that is currently undergoing phase 3 clinical trials…

Danielle Pillsbury2014年6月1日

Publication

The ISoP Standards and Best Practices Committee

The mission of the International Society of Pharmacometrics (ISoP) Standards and Best Practices Committee is…

Danielle Pillsbury2014年6月1日

Publication

The Posology of Oseltamivir in Infants with Influenza Infection Using a Population Pharmacokinetic Approach

Danielle Pillsbury2014年5月27日

Publication

Model-based Meta-analysis for Quantifying Paclitaxel Dose Response in Cancer Patients

Model-based meta-analysis of dose response is a sophisticated method to guide dose and regimen selection.…

Danielle Pillsbury2014年5月21日

Poster

Modeling the Binding Kinetics of Bispecific Antibodies under the Framework of a Minimal Human PBPK Model

Danielle Pillsbury2014年5月19日

Publication

Improving the Assessment of Heart Toxicity for All New Drugs Through Translational Regulatory Science

Fourteen drugs have been removed from the market worldwide because they cause torsade de pointes.…

Danielle Pillsbury2014年5月1日

Publication

Changes in Individual Drug-independent System Parameters during Virtual Pediatric Pharmacokinetic Trials: Introducing Time-varying Physiology into a Pediatric PBPK Model

Although both POPPK and physiologically based pharmacokinetic (PBPK) models can account for age and other covariates within…

Danielle Pillsbury2014年5月1日

Publication

Evaluation of Tumor Size Response Metrics to Predict Survival in Oncology Clinical Trials

Model-based drug development in oncology is still lagging despite a good momentum in the clinical…

Danielle Pillsbury2014年4月1日

Publication

Exploratory Modeling and Simulation to Support Development of Motesanib in Asian Patients with Non-small Cell Lung Cancer Based on MONET1 Study Results

The motesanib phase III MONET1 study failed to show improvement in overall survival (OS) in…

Danielle Pillsbury2014年4月1日

Publication

Physiologically-based Pharmacokinetic Modeling Framework for Quantitative Prediction of an Herb–Drug Interaction

Herb–drug interaction predictions remain challenging. Physiologically based pharmacokinetic (PBPK) modeling was used to improve prediction…

Danielle Pillsbury2014年3月26日

Powered by Translations.com GlobalLink Web Software

pre-update

Activities of Ceftazidime and Avibactam Against β-lactamase-producing Enterobacteriaceae in a Hollow-fiber Pharmacodynamic Model

The ISoP Standards and Best Practices Committee

The Posology of Oseltamivir in Infants with Influenza Infection Using a Population Pharmacokinetic Approach

Model-based Meta-analysis for Quantifying Paclitaxel Dose Response in Cancer Patients

Modeling the Binding Kinetics of Bispecific Antibodies under the Framework of a Minimal Human PBPK Model

Improving the Assessment of Heart Toxicity for All New Drugs Through Translational Regulatory Science

Changes in Individual Drug-independent System Parameters during Virtual Pediatric Pharmacokinetic Trials: Introducing Time-varying Physiology into a Pediatric PBPK Model

Evaluation of Tumor Size Response Metrics to Predict Survival in Oncology Clinical Trials

Exploratory Modeling and Simulation to Support Development of Motesanib in Asian Patients with Non-small Cell Lung Cancer Based on MONET1 Study Results

Physiologically-based Pharmacokinetic Modeling Framework for Quantitative Prediction of an Herb–Drug Interaction

メルマガ登録

クイックアクセス

ソリューション

お問合せ